Pulmonx Corporation (LUNG) Cash Flow Statement
Pulmonx Corporation (LUNG) generated -$30.6M of operating cash flow over the twelve months to 2026-06-30, spent $112000 on capital expenditure and had free cash flow of -$30.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LUNGPulmonx CorporationFollow LUNG — free
—
Price chart with a free account
- Market cap
- 78.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -30.6 | -41.4 | -45.1 | -37.6 | -31.5 | -32.4 | -30.6 | |
| Capital expenditure | 0.9 | 3.7 | 1.3 | 0.8 | 1.4 | 0.5 | -0.1 | |
| Free cash flow | -31.5 | -45.1 | -46.4 | -38.4 | -33.0 | -32.8 | -30.7 | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Share repurchases | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | |
| Stock-based compensation | 3.2 | 10.5 | 16.4 | 22.1 | 23.0 | 21.2 | — |
USD millions · SEC XBRL
Pulmonx Corporation — questions
- What is Pulmonx Corporation's operating cash flow?
- -$30.6M over the twelve months to 2026-06-30.
- How much does Pulmonx Corporation spend on capital expenditure?
- $112000 over the twelve months to 2026-06-30.
- What is Pulmonx Corporation's free cash flow?
- -$30.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Pulmonx Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.